Last updated on November 2016

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease


Brief description of study

This is a non-interventional, multinational, multi-center post-marketing study, to further document the safety and efficacy of pasireotide s.c. administered in routine clinical practice in patients with Cushing's disease. Patients with Cushing's disease and treated with pasireotide s.c. alone and in combination with other therapies will be monitored. For this study, each enrolled patient will be followed up for 3 years after enrollment. Patients who permanently discontinue pasireotide s.c. prior to completing the 3-year observation period will be followed up for 3 months after the last dose of pasireotide s.c.

Clinical Study Identifier: NCT02310269

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

John Carmichael

University of Southern California CSOM230B2410 - SC
Los Angeles, CA United States
  Connect »

Novartis Pharmaceuticals

Diabetes Research Institute SC
Miami, FL United States
  Connect »

Novartis Pharmaceuticals

LifeBridge Heath Cardiovascular Institute, Sinai Hospital SC - SOM230B2410
Baltimore, MD United States
  Connect »

Nicholas Tritos

Massachusetts General Hospital SC - SOM230B2410
Boston, MA United States
  Connect »

Lawrence Kirschner

Ohio State University SC - SOM230B2410
Columbus, OH United States
  Connect »

Travis Monchamp

Endocrinology Services
Bend, OR United States
  Connect »

Murray B. Gordon

Allegheny Endocrinology Associates
Pittsburgh, PA United States
  Connect »

Geetha Gopalakrishnan

R. I. Hospital Medical Oncology Clinical Research SC
Providence, RI United States
  Connect »

Kevin Yuen

Swedish Medical Center Dept.ofSeattle Neuroscience(2)
Seattle, WA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Montreal, QC Canada
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Sherbrooke, QC Canada
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Quebec, QC Canada
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Cali, Colombia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Amiens cedex 1, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bron Cedex, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Dijon, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Lille Cedex, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Marseille Cédex 5, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Montpellier Cedex 5, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Reims, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
St Priest en Jarez Cedex, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Strasbourg, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Mannheim, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Aachen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Berlin, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Duesseldorf, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Erlangen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Essen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Frankfurt, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Freiburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Halle, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hamburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hannover, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leipzig, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Magdeburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Marburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Muenchen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Muenster, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
München, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Oldenburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Würzburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Petach Tikva, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Tel Aviv, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ancona, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Messina, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Milano, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Palermo, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Padova, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Pisa, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Torino, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Napoli, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Beirut, Lebanon
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Maastricht, Netherlands
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nijmegen, Netherlands
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bucuresti, Romania
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Cluj, Romania
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Tg. Mures, Romania
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Gothenburg, Sweden
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Uppsala, Sweden
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Plymouth, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Southampton, United Kingdom
  Connect »